McCarthy Sean A. bought CTMX
November 6, 2025 · Form 4 insider transaction
McCarthy Sean A. bought 101,793 shares of CytomX Therapeutics, Inc. at $1.59 per share, a transaction worth $161.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 344 days after the transaction.
Footnotes
This Form 4/A restates in its entirety the original Form 4 filed on 11/10/2025 (the "Original Form 4") to report an inadvertently omitted exercise that was part of a same-day exercise-and-sale transaction; the sale was timely reported in the Original Form 4. Due to the omission, the Original Form 4 understated the Reporting Person's direct holdings following the reported transactions by 101,793 shares, and this understatement carried forward into Column 5 of Table I of the Reporting Person's Forms 4 filed on 2/4/2026 and 3/19/2026 (the "Subsequent Reports"). The direct holdings reported in Column 5 of Table I of this Form 4/A have been corrected. The Subsequent Reports are not being amended; the direct holdings amounts reported therein should each be read as increased by 101,793 shares.; Includes 488,750 restricted stock units.